| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 01/14/1992 | US5080907 Pharmaceutical preparations containing non-steroidal anti-inflammatory agents |
| 01/14/1992 | US5080906 Method and composition for oral administration of n-acetylcysteine |
| 01/14/1992 | US5080898 Enzymatically active toxin coupled to a cell-specific ligand |
| 01/14/1992 | US5080896 Synthetic immunogen |
| 01/14/1992 | US5080891 Conjugates of superoxide dismutase coupled to high molecular weight polyalkylene glycols |
| 01/14/1992 | US5080833 Immobilization of bioactive substance on lipid composition containing modified lipid compound |
| 01/14/1992 | CA2087194A1 Targeted drug delivery via phosphonate derivatives |
| 01/14/1992 | CA2066731A1 Liquid oral pharmaceutical compositions having anti-inflammatory activity |
| 01/14/1992 | CA2066416A1 Method for preparing a lipoprotein modified by the incorporation of a lipophilic active substance |
| 01/14/1992 | CA1294215C Pharmaceutical compositions of recombinant beta-interferon and formulation processes |
| 01/13/1992 | CA2044663A1 Water-dispersible polyene antifungal complexes |
| 01/09/1992 | WO1992000383A1 Antibodies specific for the transglutaminase-induced isopeptide bond |
| 01/09/1992 | WO1992000286A1 N-alkyl 1-oxo and 1,1-dioxo 3-thiamorpholinones and uses thereof as permeating agents for active compounds in therapeutical and cosmetic compositions |
| 01/09/1992 | WO1992000107A1 Aerosol drug formulations |
| 01/09/1992 | WO1992000106A2 Method of treatment and compositions therefore |
| 01/09/1992 | WO1992000105A1 Water insoluble derivatives of hyaluronic acid |
| 01/09/1992 | WO1992000104A1 Mucosal delivery systems for treatment of periodontal disease |
| 01/09/1992 | WO1992000091A1 Random bio-oligomer library, a method of synthesis thereof, and a method of use thereof |
| 01/09/1992 | WO1992000061A1 Pressurised aerosol compositions |
| 01/09/1992 | WO1992000044A1 Ophthalmic suspensions |
| 01/09/1992 | CA2083821A1 Aerosol drug formulations |
| 01/08/1992 | EP0465338A1 Process for the preparation of granulates of actives through extrusion |
| 01/08/1992 | EP0465337A1 Smoothing process for granulates of actives |
| 01/08/1992 | EP0465081A1 Viral decoy vaccine |
| 01/08/1992 | EP0464175A1 Extracellular form of the human fibroblast growth factor receptor |
| 01/08/1992 | EP0464163A1 Use of supercritical fluids to obtain porous sponges of biodegradable polymers. |
| 01/08/1992 | EP0464135A1 Method for reducing side effects of a drug. |
| 01/08/1992 | EP0464077A1 Process for the preparation of a ligand-receptor complex. |
| 01/08/1992 | EP0160051B1 Foamable biocide composition |
| 01/07/1992 | WO1992000748A1 Poly(alkylene oxide) amino acid copolymers and drug carriers and charged copolymers based thereon |
| 01/07/1992 | US5079353 Sialic acid glycosides, antigens, immunoadsorbents, and methods for their preparation |
| 01/07/1992 | US5079344 Monoclonal antibodies, hybridomas or cells |
| 01/07/1992 | US5079265 Composition and methods for providing optimum bioavailability of the active ingredient 2-hydroxy-5-methyllaurophenoxime (hmlo) |
| 01/07/1992 | US5079237 Improved water solubility |
| 01/07/1992 | US5079156 Crosslinked Polyvinyl Acylate Polymers |
| 01/07/1992 | US5079018 Readily Dissovable Gelatin Carrier |
| 01/07/1992 | US5079000 Fungicides, bactericides, insecticides useful for stored fruits and vegetables, natural products |
| 01/07/1992 | US5078997 Pharmaceutical composition for interleukin-2 containing physiologically compatible stabilizers |
| 01/07/1992 | US5078993 Ointment pharmaceutical formulation |
| 01/07/1992 | US5078680 Automatic injector for emergency treatment |
| 01/07/1992 | CA2086528A1 Poly(alkylene oxide) amino acid copolymers and drug carriers and charged copolymers based thereon |
| 01/06/1992 | WO1992000762A1 Receptor directed-toxin conjugates |
| 01/06/1992 | CA2086679A1 Receptor directed-toxin conjugates |
| 01/04/1992 | WO1992000763A1 Immunoreactive compound |
| 01/04/1992 | CA2086531A1 Immunoreactive compound |
| 01/03/1992 | WO1992000064A1 Process for producing pressed, moulded, delayed release dose units and dose units thus produced |
| 01/02/1992 | EP0463962A1 Preparation of fatty product microspheres loaded or not with an active substance |
| 01/02/1992 | EP0463877A1 Controlled release pharmaceutical preparation |
| 01/02/1992 | EP0463833A2 Controlled release pharmaceutical preparation and process for preparing same |
| 01/02/1992 | EP0463653A1 Galenic formulations containing cyclodextrins |
| 01/02/1992 | EP0463228A2 Injectable formulations containing the sodium salt of naproxen |
| 01/02/1992 | EP0463190A1 Minerals in bioavailable form |
| 01/02/1992 | EP0451299A4 Magnetocontrollable carrier with physiologically active substance and method for making said carrier |
| 01/02/1992 | EP0359738B1 Preparation to improve the keeping qualities of foodstuffs, drugs and cosmetic products |
| 01/02/1992 | EP0177573B1 Biodegradable matrix and methods for producing same |
| 01/01/1992 | CN1057457A Synthesis process of permeate agent azoen |
| 12/31/1991 | US5077389 Chemical product usable as a non-radioactive carrier |
| 12/31/1991 | US5077310 Granulation product of calcium ascorbate |
| 12/31/1991 | US5077216 Monoclonal antibodies specific for a human mononculear phagocyte-specific antigen |
| 12/31/1991 | US5077058 Microspheres impregnated with a drug or cosmetic |
| 12/31/1991 | US5077057 Preparation of liposome and lipid complex compositions |
| 12/31/1991 | US5077055 Topical therapeutic system comprising 5-fluorouracil |
| 12/31/1991 | US5077053 Sorbitol with multiple coating layers |
| 12/31/1991 | US5077052 Chitosan derivatives useful in compositions for coating feedstuff additives intended for ruminants |
| 12/31/1991 | US5077051 Sustained release of active agents from bioadhesive microcapsules |
| 12/31/1991 | US5077033 Ophthalmic drug delivery with thermo-irreversible gels of polxoxyalkylene polymer and ionic polysaccharide |
| 12/30/1991 | WO1992000089A1 Immunotoxin complex |
| 12/30/1991 | WO1992000063A1 Method for smoothing granules of active principles |
| 12/30/1991 | CA2065048A1 Immunotoxin conjugate |
| 12/30/1991 | CA2064056A1 Process for the smoothing of active ingredient granules |
| 12/29/1991 | WO1992000077A1 Improved ointment base and method of use |
| 12/29/1991 | CA2086254A1 Ointment base and method of use |
| 12/28/1991 | WO1992000099A1 Method of introducing a peptide into the cytosol |
| 12/28/1991 | WO1992000062A1 The use of soluble fluorosurfactants for the preparation of metered-dose aerosol formulations |
| 12/28/1991 | WO1991016914A1 Methods and preparations of stable, deodorized oils and pharmaceutical compositions thereof |
| 12/28/1991 | CA2086342A1 Method of introducing a peptide into a cytosol |
| 12/28/1991 | CA2086096A1 Use of soluble fluorosurfactants for the preparation of metered-dose aerosol formulations |
| 12/28/1991 | CA2082418A1 Methods and preparations of stable, deodorized oils and pharmaceutical compositions thereof |
| 12/27/1991 | EP0462959A1 Coated veterinary implants. |
| 12/27/1991 | EP0462787A1 Radiopharmaceutical formulations, their method of administration and process of preparation |
| 12/27/1991 | EP0462388A2 Coated particles, hollow particles, and process for manufacturing the same |
| 12/27/1991 | EP0462215A1 MOLECULAR CLONING OF GENOMIC AND cDNA SEQUENCES ENCODING CELLULAR RECEPTORS FOR POLIOVIRUS |
| 12/27/1991 | EP0224545B1 Pharmaceutical depot preparation |
| 12/26/1991 | WO1992000109A1 Bioceramic system for delivery of bioactive compounds |
| 12/26/1991 | WO1991019813A1 Nucleic acid ligands |
| 12/26/1991 | WO1991019510A1 Osteoinductive pharmaceutical formulations |
| 12/26/1991 | WO1991019501A1 Intercellular adhesion mediators |
| 12/26/1991 | WO1991019491A1 Use of calcium soap for the treatment of inflammatory skin reactions in horses and ponies |
| 12/26/1991 | WO1991019483A1 Compositions and methods for the controlled release of soluble active substances |
| 12/26/1991 | WO1991019482A1 Aminosteroids for ophthalmic use |
| 12/26/1991 | WO1991019481A1 Reversible gelation compositions and methods of use |
| 12/26/1991 | WO1991019470A1 Polyurethane-biopolymer composite |
| 12/26/1991 | WO1991017773A3 New protein-polycation conjugates |
| 12/26/1991 | CA2086095A1 Bioceramic system for delivery of bioactive compounds |
| 12/25/1991 | CN1057275A Non-destructive carriers for cyclodextrin complexes |
| 12/25/1991 | CN1057192A Mfg. technology of medicated oil (for rheumatism) polyurethane sponge |
| 12/24/1991 | US5075295 Novel oxytetracycline compositions |
| 12/24/1991 | US5075291 Crystalline sugar alcohol containing uniformly dispersed particulate pharmaceutical compound |
| 12/24/1991 | US5075230 Stabilized plasminogen activator precursor and method of producing the same |
| 12/24/1991 | US5075114 Taste masking and sustained release coatings for pharmaceuticals |